• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Jagged1 作为一种 RBP-J 靶标和反馈抑制物,抑制 TNF 介导的炎症性破骨细胞发生。

Jagged1 Acts as an RBP-J Target and Feedback Suppresses TNF-Mediated Inflammatory Osteoclastogenesis.

机构信息

Arthritis and Tissue Degeneration Program, David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY.

Department of Medicine, Weill Cornell Medical College, New York, NY.

出版信息

J Immunol. 2023 Nov 1;211(9):1340-1347. doi: 10.4049/jimmunol.2300317.

DOI:10.4049/jimmunol.2300317
PMID:37756541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10693321/
Abstract

TNF plays a crucial role in inflammation and bone resorption in various inflammatory diseases, including rheumatoid arthritis (RA). However, its direct ability to drive macrophages to differentiate into osteoclasts is limited. Although RBP-J is recognized as a key inhibitor of TNF-mediated osteoclastogenesis, the precise mechanisms that restrain TNF-induced differentiation of macrophages into osteoclasts are not fully elucidated. In this study, we identified that the Notch ligand Jagged1 is a previously unrecognized RBP-J target. The expression of Jagged1 is significantly induced by TNF mainly through RBP-J. The TNF-induced Jagged1 in turn functions as a feedback inhibitory regulator of TNF-mediated osteoclastogenesis. This feedback inhibition of osteoclastogenesis by Jagged1 does not exist in RANKL-induced mouse osteoclast differentiation, as RANKL does not induce Jagged1 expression. The Jagged1 level in peripheral blood monocytes/osteoclast precursors is decreased in RA compared with the nonerosive inflammatory disease systemic lupus erythematosus, suggesting a mechanism that contributes to increased osteoclast formation in RA. Moreover, recombinant Jagged1 suppresses human inflammatory osteoclastogenesis. Our findings identify Jagged1 as an RBP-J direct target that links TNF and Notch signaling pathways and restrains TNF-mediated osteoclastogenesis. Given that Jagged1 has no effect on TNF-induced expression of inflammatory genes, its use may present a new complementary therapeutic approach to mitigate inflammatory bone loss with little impact on the immune response in disease conditions.

摘要

肿瘤坏死因子(TNF)在各种炎症性疾病中,包括类风湿关节炎(RA)中,发挥着关键作用,它在炎症和骨吸收中起着关键作用。然而,它直接驱动巨噬细胞分化为破骨细胞的能力有限。尽管 RBP-J 被认为是 TNF 介导的破骨细胞生成的关键抑制剂,但限制 TNF 诱导巨噬细胞分化为破骨细胞的确切机制尚未完全阐明。在这项研究中,我们发现 Notch 配体 Jagged1 是 RBP-J 的一个以前未被识别的靶点。Jagged1 的表达主要通过 RBP-J 被 TNF 显著诱导。TNF 诱导的 Jagged1 反过来作为 TNF 介导的破骨细胞生成的反馈抑制调节剂发挥作用。这种 Jagged1 对破骨细胞生成的反馈抑制在 RANKL 诱导的小鼠破骨细胞分化中不存在,因为 RANKL 不会诱导 Jagged1 的表达。与非侵蚀性炎症性疾病系统性红斑狼疮相比,RA 患者外周血单核细胞/破骨细胞前体中的 Jagged1 水平降低,提示这是导致 RA 中破骨细胞形成增加的一种机制。此外,重组 Jagged1 抑制人炎症性破骨细胞生成。我们的研究结果表明 Jagged1 是一个 RBP-J 的直接靶点,它连接了 TNF 和 Notch 信号通路,并限制了 TNF 介导的破骨细胞生成。鉴于 Jagged1 对 TNF 诱导的炎症基因表达没有影响,其应用可能为减轻炎症性骨丢失提供一种新的补充治疗方法,而对疾病状态下的免疫反应影响不大。

相似文献

1
Jagged1 Acts as an RBP-J Target and Feedback Suppresses TNF-Mediated Inflammatory Osteoclastogenesis.Jagged1 作为一种 RBP-J 靶标和反馈抑制物,抑制 TNF 介导的炎症性破骨细胞发生。
J Immunol. 2023 Nov 1;211(9):1340-1347. doi: 10.4049/jimmunol.2300317.
2
RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.RBP-J调控的miR-182促进肿瘤坏死因子-α诱导的破骨细胞生成。
J Immunol. 2016 Jun 15;196(12):4977-86. doi: 10.4049/jimmunol.1502044. Epub 2016 May 9.
3
Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption.肿瘤坏死因子(TNF)介导热激性破骨细胞发生和骨吸收的固有限制。
Front Endocrinol (Lausanne). 2020 Oct 8;11:583561. doi: 10.3389/fendo.2020.583561. eCollection 2020.
4
TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J.转录因子 RBP-J 抑制 TNF 诱导的破骨细胞生成和炎症性骨吸收。
J Exp Med. 2012 Feb 13;209(2):319-34. doi: 10.1084/jem.20111566. Epub 2012 Jan 16.
5
Bub1 suppresses inflammatory arthritis-associated bone loss in mice through inhibition of TNFα-mediated osteoclastogenesis.Bub1 通过抑制 TNFα 介导体细胞骨吸收抑制小鼠炎症性关节炎相关的骨丢失。
J Bone Miner Res. 2024 Apr 19;39(3):341-356. doi: 10.1093/jbmr/zjae015.
6
Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways.艾拉莫德通过调节RANKL和TNF-α信号通路抑制破骨细胞生成。
Int Immunopharmacol. 2021 Jan;90:107219. doi: 10.1016/j.intimp.2020.107219. Epub 2020 Dec 9.
7
Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.Def6抑制破骨细胞生成和炎症性骨吸收。
J Immunol. 2017 May 1;198(9):3436-3447. doi: 10.4049/jimmunol.1601716. Epub 2017 Mar 17.
8
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling.脂多糖-TLR4 轴通过调控破骨细胞生成而不依赖于 RANKL/RANK 信号通路。
BMC Immunol. 2021 Mar 25;22(1):23. doi: 10.1186/s12865-021-00409-9.
9
Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption.RBP-J/NFATc1-miR182 调控网络控制炎症性骨吸收。
FASEB J. 2020 Feb;34(2):2392-2407. doi: 10.1096/fj.201902227R. Epub 2019 Dec 23.
10
TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis.TGFβ 重新编程 TNF 对巨噬细胞的刺激,使其走向非经典途径,从而驱动炎症性破骨细胞生成。
Nat Commun. 2022 Jul 7;13(1):3920. doi: 10.1038/s41467-022-31475-1.

引用本文的文献

1
Another Notch in the Belt of Rheumatoid Arthritis.类风湿关节炎的又一进展
Arthritis Rheumatol. 2024 Oct;76(10):1475-1487. doi: 10.1002/art.42937. Epub 2024 Aug 9.

本文引用的文献

1
TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis.TGFβ 重新编程 TNF 对巨噬细胞的刺激,使其走向非经典途径,从而驱动炎症性破骨细胞生成。
Nat Commun. 2022 Jul 7;13(1):3920. doi: 10.1038/s41467-022-31475-1.
2
Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption.肿瘤坏死因子(TNF)介导热激性破骨细胞发生和骨吸收的固有限制。
Front Endocrinol (Lausanne). 2020 Oct 8;11:583561. doi: 10.3389/fendo.2020.583561. eCollection 2020.
3
Osteoimmunology of Bone Loss in Inflammatory Rheumatic Diseases.炎症性风湿病中的骨丢失的骨免疫学。
Front Immunol. 2019 Apr 3;10:679. doi: 10.3389/fimmu.2019.00679. eCollection 2019.
4
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids.开发一种分子标记物,以监测体内给予糖皮质激素介导的药效反应。
Arthritis Rheumatol. 2018 Aug;70(8):1331-1342. doi: 10.1002/art.40476. Epub 2018 Jul 12.
5
Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis.缺氧敏感的COMMD1整合人类巨噬细胞中的信号传导与细胞代谢并抑制破骨细胞生成。
Immunity. 2017 Jul 18;47(1):66-79.e5. doi: 10.1016/j.immuni.2017.06.018.
6
TNF and Bone Remodeling.肿瘤坏死因子与骨重塑
Curr Osteoporos Rep. 2017 Jun;15(3):126-134. doi: 10.1007/s11914-017-0358-z.
7
Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics.地诺单抗停用后与反弹相关的椎体骨折——来自临床和生物力学研究
Osteoporos Int. 2016 May;27(5):1917-21. doi: 10.1007/s00198-015-3458-6. Epub 2015 Dec 22.
8
TNF biology, pathogenic mechanisms and emerging therapeutic strategies.肿瘤坏死因子的生物学特性、致病机制及新出现的治疗策略。
Nat Rev Rheumatol. 2016 Jan;12(1):49-62. doi: 10.1038/nrrheum.2015.169. Epub 2015 Dec 10.
9
Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials.地诺单抗与颌骨坏死。对临床试验中报告事件的系统分析。
Clin Oral Implants Res. 2016 Mar;27(3):367-75. doi: 10.1111/clr.12556. Epub 2015 Feb 2.
10
limma powers differential expression analyses for RNA-sequencing and microarray studies.limma为RNA测序和微阵列研究提供差异表达分析的动力。
Nucleic Acids Res. 2015 Apr 20;43(7):e47. doi: 10.1093/nar/gkv007. Epub 2015 Jan 20.